Strata Critical Medical Business Summary

Strata Critical Medical, Inc. (SRTA) operates as a specialized, time-critical logistics and medical services provider primarily serving the U.S. organ transplant and cardiovascular surgery sectors. The company generates revenue through a high-margin, asset-light model, charging service fees for its integrated "one-call" solution that encompasses air and ground organ transportation, surgical recovery, organ placement, and normothermic regional perfusion (NRP). Its business is bifurcated into two primary segments: Logistics Services, which manages a nationwide network of third-party aircraft and ground vehicles, and Clinical Services, which provides perfusion staffing and equipment through its Trinity Medical Solutions and Keystone Perfusion brands. Strata positions itself as a dominant market leader in organ transport logistics, competing directly with TransMedics Group, Inc., Viemed Healthcare, Inc., and Cross Country Healthcare, Inc. by offering a technology-agnostic platform that prioritizes rapid response times and end-to-end clinical integration over proprietary hardware. The company is led by Co-CEOs Melissa Tomkiel and William Heyburn, who also serve as General Counsel and Chief Financial Officer, respectively; both were instrumental in the company’s 2025 pivot from passenger aviation (formerly Blade Air Mobility) to a pure-play medical services firm. Tomkiel brings a deep pedigree in aviation law and operations as the former president of Fly The Whale, while Heyburn’s background includes growth equity at RedBird Capital Partners and restructuring at Moelis & Company. The leadership team is supported by Chairman Robert Wiesenthal, the former CEO of Blade and a veteran executive from Warner Music Group and Sony. Strata maintains a high-profile investor base and board, including notable directors such as Susan Lyne (BBG Ventures) and Will Cook (CEO of Vail Health), with significant institutional backing from Ark Investment Management, Third Point LLC, and BlackRock.